|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 6:69–90. 2011. View Article : Google Scholar
|
|
2
|
Bosch FX, Ribes J, Diaz M, et al: Primary
liver cancer: worldwide incidence and trends. Gastroenterology.
127:S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perz JF, Armstrong GL, Farrington LA, et
al: The contributions of hepatitis B virus and hepatitis C virus
infections to cirrhosis and primary liver cancer worldwide. J
Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu H, Wang Y, Zhang Y, et al: TFAR19, a
novel apoptosis related gene cloned from human leukemia cell line
TF21, could enhance apoptosis of some tumor cells induced by growth
factor withdrawal. Biochem Biophys Res Commun. 254:203–210. 1999.
View Article : Google Scholar
|
|
5
|
Spinola M, Meyer P, Kammerer S, et al:
Association of the PDCD5 locus with lung cancer risk and prognosis
in smokers. J Clin Oncol. 24:1672–1678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu D, Feng Y, Cheng Y, et al: Human
programmed cell death 5 protein has a helical-core and two
dissociated structural regions. Biochem Biophys Res Commun.
318:391–396. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hedenfalk I, Duggan D, Chen Y, et al:
Gene-expression profiles in hereditary breast cancer. N Engl J Med.
344:539–548. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Zhao M, Li W, et al: Expression of
programmed cell death 5 gene involves in regulation of apoptosis in
gastric tumor cells. Apoptosis. 11:993–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Wang Q, Gao F, et al: Reduced
expression of PDCD5 is associated with high-grade astrocytic
gliomas. Oncol Rep. 20:573–579. 2008.PubMed/NCBI
|
|
10
|
Ruan G, Qin Y, Chen S, et al: Abnormal
expression of the programmed cell death 5 gene in acute and chronic
myeloid leukemia. Leuk Res. 30:1159–1165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng YM, Zhang YM and Jing GZ: Soluble
expression in Escherichia coli, purification and characterization
of a human TF-1 cell apoptosis-related protein TFAR19. Protein Expr
Purif. 25:323–329. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Guan Z and Ge Z: Plasma and
synovial fluid programmed cell death 5 (PDCD5) levels are inversely
associated with TNF-α and disease activity in patients with
rheumatoid arthritis. Biomarkers. 18:155–159. 2013.PubMed/NCBI
|
|
13
|
Wang Y, Wang GH and Zhang QY:
Determination of PDCD5 in peripheral blood serum of cancer
patients. Chin J Cancer Res. 23:224–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu L, Chen Y, Song Q, et al: PDCD5
interacts with Tip60 and functions as a cooperator in
acetyltransferase activity and DNA damage-induced apoptosis.
Neoplasia. 11:345–354. 2009.PubMed/NCBI
|
|
15
|
Xu L, Hu J, Zhao Y, et al: PDCD5 interacts
with p53 and functions as a positive regulator in the p53 pathway.
Apoptosis. 17:1235–1245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li H, Zhang X, Song X, et al: PDCD5
promotes cisplatin-induced apoptosis of glioma cells via activating
mitochondrial apoptotic pathway. Cancer Biol Ther. 13:822–830.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han XR, Sun Y and Bai XZ: The antitumor
role and mechanism of integrated and truncated PDCD5 proteins in
osteosarcoma cells. Cell Signal. 24:1713–1721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berman DM, Karhadkar SS, Maitra A, et al:
Widespread requirement for Hedgehog ligand stimulation in growth of
digestive tract tumours. Nature. 425:846–851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Markaryan A, Nelson EG, Tretiakova M, et
al: Technical report: immunofluorescence and TUNEL staining of
celloidin embedded human temporal bone tissues. Hear Res. 241:1–6.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fekete MR, McBride WH and Pajonk F:
Anthracyclines, proteasome activity and multi-drug-resistance. BMC
Cancer. 5:1142005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu XR, Huang J, Xu ZG, et al: Insight into
hepatocellular carcinogenesis at transcriptome level by comparing
gene expression profiles of hepatocellular carcinoma with those of
corresponding non-cancer liver. Proc Natl Acad Sci USA.
98:15089–15094. 2001. View Article : Google Scholar
|
|
22
|
Chen C, Zhou H, Xu L, et al: Prognostic
significance of downregulated expression of programmed cell death 5
in chondrosarcoma. J Surg Oncol. 102:838–843. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dudich E, Semenkova L, Gorbatova E, et al:
Growth - regulative activity of human alpha-fetoprotein for
different types of tumor and normal cells. Tumour Biol. 19:30–40.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang XW and Xu B: Stimulation of tumor -
cell growth by alpha-fetoprotein. Int J Cancer. 75:596–599. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang JF, Guan ZP, Zhang SL, et al:
Programmed cell death 5 correlates with disease activity and
interleukin-17 in serum and synovial fluid of rheumatoid arthritis
patients. Chin Med J (Engl). 126:296–299. 2013.PubMed/NCBI
|
|
26
|
Wang Y, Li X, Wang L, et al: An
alternative form of paraptosis like cell death, triggered by
TAJ/TROYand enhanced by PDCD5 overexpression. J Cell Sci.
117:1525–1532. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Sun R, Han W, et al: Nuclear
translocation of PDCD5 (TFAR19): an early signal for apoptosis?
FEBS Lett. 509:191–196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rui M, Chen YY, Zhang YM, et al: Transfer
of anti-TFAR19 monoclonal antibody into HeLa cells by in situ
electroporation can inhibit the apoptosis. Life Sci. 71:1771–1778.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen LN, Wang Y, Ma DL, et al: Short
interfering RNA against the PDCD5 attenuates cell apoptosis and
caspase-3 activity induced by Bax overexpression. Apoptosis.
11:101–111. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salvi M, Xu D, Chen Y, et al: Programmed
cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and
in 293T cells. Biochem Biophys Res Commun. 387:606–610. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
An L, Zhao X, Wu J, et al: Involvement of
autophagy in cardiac remodeling in transgenic mice with cardiac
specific over-expression of human programmed cell death 5. PLoS
One. 7:e300972012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Adams J: The development of proteasome
inhibitors as anticancer drugs. Cancer Cell. 5:417–421. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu WK, Cho CH, Lee CW, et al: Proteasome
inhibition: a new therapeutic strategy to cancer treatment. Cancer
Lett. 293:15–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
